{"id":17457,"date":"2014-01-08T02:30:00","date_gmt":"2014-01-08T01:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/riordino-professioni-titolarita-e-sperimentazione-al-via-discussione-ddl-%c2%93omnibus%c2%94\/"},"modified":"2014-01-08T02:30:00","modified_gmt":"2014-01-08T01:30:00","slug":"riordino-professioni-titolarita-e-sperimentazione-al-via-discussione-ddl-%c2%93omnibus%c2%94","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/riordino-professioni-titolarita-e-sperimentazione-al-via-discussione-ddl-%c2%93omnibus%c2%94\/","title":{"rendered":"Reorganization of professions, ownership and experimentation: discussion of the "omnibus" bill underway"},"content":{"rendered":"

Tuesday, April 23, 2013 HPS<\/span><\/p>\n

<\/span><\/font><\/p>\n

Of <\/span>Marco Giorgetti<\/span><\/a><\/span><\/b><\/font>
<\/span>AboutPharma and Medical Devices<\/font><\/span><\/a><\/span><\/p>\n

<\/span><\/p>\n

Novartis, J&J and Sanofi are in first place, but many companies have made staff cuts <\/p>\n

<\/font><\/span><\/p>\n

Fierce Pharma released a controversial ranking: a ranking of the drug giants based on the number of employees<\/b>. The company that employs more personnel "wins" and then gradually, decreasingly, the other positions are defined. It is by no means certain that having a large number of employees is synonymous with good health for the pharmaceutical company: AboutPharma and Medical Devices<\/i> of May will propose examples of microscopic biotechs, with about twenty employees, which are not only listed on the Stock Exchange, but attract investments in R&D by the multinational giants.<\/p>\n

<\/font><\/span><\/p>\n

In principle, the largest companies have proceeded to make staff cuts in recent months, but this does not mean that they will continue on this path.<\/p>\n

<\/font><\/span><\/p>\n

Beyond the<\/p>","protected":false},"excerpt":{"rendered":"

martedì 23 aprile 2013 HPS di Marco Giorgetti AboutPharma and Medical Devices Ai primi posti Novartis, J&J e Sanofi, ma molte aziende hanno effettuato tagli di personale Fierce Pharma ha pubblicato una classifica controversa: una graduatoria dei colossi del farmaco stilata in base al numero di dipendenti. "Vince" l’azienda che impiega più personale e poi …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17457","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17457"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17457\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}